Karachi, Citi Pharma Ltd has declared a considerable profit in its half-year financial results ended December 31, 2023. The pharmaceutical company noted a profit before tax of PKR 753.124 million and an after-tax profit of PKR 470.052 million. The earnings per share (EPS) stood at PKR 2.06. These financials were presented without clarification on their consolidation status, and no related entitlements were disclosed.